Combination therapy in rheumatoid arthritis

被引：5

作者：

Bingham, S ^{[1
]}

Emery, P ^{[1
]}

机构：

[1] Univ Leeds, Res Unit, Leeds LS2 9NZ, W Yorkshire, England

来源：

SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 2001年 / 23卷 / 1-2期

关键词：

D O I：

10.1007/s002810100069

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：165 / 183

页数：19

共 70 条

[1]

Antoni C, 1999, CLIN EXP RHEUMATOL, V17, pS73

[2] INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].

AREND, WP ;

DAYER, JM .

ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160

[3]

BENSEN W, 1994, J RHEUMATOL, V21, P2034

[4]

BITTER T, 1984, CLIN RHEUM DIS, V10, P417

[5] Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].

Boers, M ;

Verhoeven, AC ;

Markusse, HM ;

vandeLaar, MAFJ ;

Westhovens, R ;

vanDenderen, JC ;

vanZeben, D ;

Dijkmans, BAC ;

Peeters, AJ ;

Jacobs, P ;

vandenBrink, HR ;

Schouten, HJA ;

vanderHeijde, DMFM ;

Boonen, A ;

vanderLinden, S .

LANCET, 1997, 350 (9074) :309-318

[6]

BRAWER AE, 1988, ARTHRITIS RHEUM S1, V31, pR10

[7]

BRENNAN FM, 1989, LANCET, V2, P244

[8]

Brennan P, 1996, BRIT MED J, V313, P471

[9]

Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO

[10]

2-2

← 1 2 3 4 5 6 7 →